158 related articles for article (PubMed ID: 7685451)
1. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
Mento PF; Maita ME; Murphy WR; Holt WF; Wilkes BM
J Cardiovasc Pharmacol; 1993 May; 21(5):791-6. PubMed ID: 7685451
[TBL] [Abstract][Full Text] [Related]
2. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
3. Combined renin and converting enzyme inhibition in rats.
Mento PF; Holt WF; Murphy WR; Wilkes BM
Hypertension; 1989 Jun; 13(6 Pt 2):741-8. PubMed ID: 2661429
[TBL] [Abstract][Full Text] [Related]
4. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
[TBL] [Abstract][Full Text] [Related]
5. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
[TBL] [Abstract][Full Text] [Related]
6. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
[TBL] [Abstract][Full Text] [Related]
7. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
[TBL] [Abstract][Full Text] [Related]
8. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
Biwer LA; Broderick TL; Xu H; Carroll C; Hale TM
Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
[TBL] [Abstract][Full Text] [Related]
9. Renal hemodynamics in rats with myocardial infarction: selective antagonism of angiotensin receptor subtypes.
Mento PF; Maita ME; Wilkes BM
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2306-12. PubMed ID: 8997287
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
[TBL] [Abstract][Full Text] [Related]
11. [Coronary and renal circulation in patients with cardiac failure after converting enzyme inhibitors].
Juliard JM; Dahan M; Solal AC; Merillon JP; Gourgon R
Presse Med; 1985 Dec; 14(44):2260-3. PubMed ID: 3003731
[TBL] [Abstract][Full Text] [Related]
12. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
[TBL] [Abstract][Full Text] [Related]
13. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
15. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
[TBL] [Abstract][Full Text] [Related]
16. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
[TBL] [Abstract][Full Text] [Related]
17. Enalapril improves arterial elastic properties in rats with myocardial infarction.
Ben Driss A; Himbert C; Poitevin P; Duriez M; Michel JB; Levy BI
J Cardiovasc Pharmacol; 1999 Jul; 34(1):102-7. PubMed ID: 10413075
[TBL] [Abstract][Full Text] [Related]
18. Greater blood pressure-lowering effect of the renin inhibitor EMD 58265 than an angiotensin-converting enzyme inhibitor in two-kidney one-clip Goldblatt rabbit.
Zimmerman BG
Clin Exp Pharmacol Physiol; 2000; 27(5-6):370-7. PubMed ID: 10831238
[TBL] [Abstract][Full Text] [Related]
19. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects on cardiac output and peripheral resistance in patients treated with enalapril after acute myocardial infarction. CONSENSUS II Multi-Echo Study Group. Cooperative New Scandinavian Enalapril Survival Study.
Edner M; Caidahl K; Bonarjee VV; Nilsen DW; Carstensen S; Berning J
Cardiology; 1998 May; 89(4):291-6. PubMed ID: 9643277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
